TME Pharma N.V. (ALTME) — Financial Flexibility Index
TME Pharma N.V. (ALTME) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of €-557.00K (operating CF €-557.00K minus capex €0.00) represents 0% of total liabilities (€3.72 Million). Check ALTME strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TME Pharma N.V. Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for TME Pharma N.V. across 12 annual periods. See TME Pharma N.V. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for TME Pharma N.V. (2014–2025)
Year-by-year free cash flow to debt coverage for TME Pharma N.V.. For the full company profile including market capitalisation, see ALTME stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.92x | €-3.42 Million | €-3.42 Million | €3.72 Million | ▲ +64.3% |
| 2024 | -2.58x | €-4.62 Million | €-4.63 Million | €1.79 Million | ▼ -27.8% |
| 2023 | -2.02x | €-5.62 Million | €-5.63 Million | €2.79 Million | ▼ -8.3% |
| 2022 | -1.86x | €-12.12 Million | €-12.14 Million | €6.51 Million | ▲ +20.7% |
| 2021 | -2.35x | €-12.37 Million | €-12.38 Million | €5.27 Million | ▼ -33.9% |
| 2020 | -1.75x | €-5.18 Million | €-5.22 Million | €2.96 Million | ▼ -47.3% |
| 2019 | -1.19x | €-4.27 Million | €-4.29 Million | €3.59 Million | ▼ -112.6% |
| 2018 | -0.56x | €-3.99 Million | €-4.00 Million | €7.12 Million | ▲ +35.9% |
| 2017 | -0.87x | €-4.24 Million | €-4.24 Million | €4.85 Million | ▲ +47.9% |
| 2016 | -1.68x | €-8.97 Million | €-8.99 Million | €5.35 Million | ▼ -62.6% |
| 2015 | -1.03x | €-13.47 Million | €-13.48 Million | €13.07 Million | ▲ +22.5% |
| 2014 | -1.33x | €-12.41 Million | €-12.46 Million | €9.33 Million | — |